This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Markwalder, R. Articles by Reubi, J. C. Search for Related Content PubMed PubMed Citation Articles by Markwalder, R. Articles by Reubi, J. C.

Gastrin-releasing Peptide Receptors in the Human Prostate

Relation to Neoplastic Transformation

Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, CH-3010 Berne, Switzerland

Bombesin-like peptides such as gastrin-releasing peptide (GRP) have been shown to play a role in cancer as autocrine growth factors that stimulate tumor growth through specific receptors. To search for potential clinical indications for GRP analogues, it is important to identify human tumor types expressing sufficient amounts of the respective receptors. In the present study, we have evaluated the expression of GRP receptors in human nonneoplastic and neoplastic prostate tissues using in vitro receptor autoradiography on tissue sections with ¹²⁵I-Tyr⁴-bombesin as radioligand. GRP receptors were detected, often in high density, in 30 of 30 invasive prostatic carcinomas and also in 26 of 26 cases of prostatic intraepithelial proliferative lesions, corresponding mostly to prostatic intraepithelial neoplasias. Well-differentiated carcinomas had a higher receptor density than poorly differentiated ones. Bone metastases of androgen-independent prostate cancers were GRP receptor-positive in 4 of 7 cases. Conversely, GRP receptors were identified in only a few hyperplastic prostates and were localized in very low density in glandular tissue and, focally, in some stromal tissue. In all of the cases, the receptors corresponded to the GRP receptor subtype of bombesin receptors, having high affinity for GRP and bombesin and lower affinity for neuromedin B. These data demonstrate a massive GRP receptor overexpression in prostate tissues that are neoplastically transformed or, like prostatic intraepithelial neoplasias, are in the process of malignant transformation. GRP receptors may be markers for early molecular events in prostate carcinogenesis and useful in differentiating prostate hyperplasia from prostate neoplasia. Such data may not only be of biological significance but may also provide a molecular basis for potential clinical applications such as GRP-receptor scintigraphy for early tumor diagnosis, radiotherapy with radiolabeled bombesin-like peptide analogues, and chemotherapy with cytotoxic bombesin analogues.

This article has been cited by other articles:

				J. Qiao, J. Kang, T. A. Ishola, P. G. Rychahou, B. M. Evers, and D. H. Chung Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma PNAS, September 2, 2008; 105(35): 12891 - 12896. [Abstract] [Full Text] [PDF]

				R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF]

				Z.-B. Li, Z. Wu, K. Chen, E. K. Ryu, and X. Chen 18F-Labeled BBN-RGD Heterodimer for Prostate Cancer Imaging J. Nucl. Med., March 1, 2008; 49(3): 453 - 461. [Abstract] [Full Text] [PDF]

				R. Cescato, T. Maina, B. Nock, A. Nikolopoulou, D. Charalambidis, V. Piccand, and J. C. Reubi Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting J. Nucl. Med., February 1, 2008; 49(2): 318 - 326. [Abstract] [Full Text] [PDF]

				Z. Salah, M. Maoz, G. Pizov, and R. Bar-Shavit Transcriptional Regulation of Human Protease-Activated Receptor 1: A Role for the Early Growth Response-1 Protein in Prostate Cancer Cancer Res., October 15, 2007; 67(20): 9835 - 9843. [Abstract] [Full Text] [PDF]

				D. Cornelio, R Roesler, and G Schwartsmann Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy Ann. Onc., September 1, 2007; 18(9): 1457 - 1466. [Abstract] [Full Text] [PDF]

				A. F. Prasanphanich, P. K. Nanda, T. L. Rold, L. Ma, M. R. Lewis, J. C. Garrison, T. J. Hoffman, G. L. Sieckman, S. D. Figueroa, and C. J. Smith [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues PNAS, July 24, 2007; 104(30): 12462 - 12467. [Abstract] [Full Text] [PDF]

				M. de Visser, W. M. van Weerden, C. M.A. de Ridder, S. Reneman, M. Melis, E. P. Krenning, and M. de Jong Androgen-Dependent Expression of the Gastrin-Releasing Peptide Receptor in Human Prostate Tumor Xenografts J. Nucl. Med., January 1, 2007; 48(1): 88 - 93. [Abstract] [Full Text] [PDF]

				L. E. Lantry, E. Cappelletti, M. E. Maddalena, J. S. Fox, W. Feng, J. Chen, R. Thomas, S. M. Eaton, N. J. Bogdan, T. Arunachalam, et al. 177Lu-AMBA: Synthesis and Characterization of a Selective 177Lu-Labeled GRP-R Agonist for Systemic Radiotherapy of Prostate Cancer J. Nucl. Med., July 1, 2006; 47(7): 1144 - 1152. [Abstract] [Full Text] [PDF]

				J. B Engel, A. V Schally, G. Halmos, B. Baker, A. Nagy, and G. Keller Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins Endocr. Relat. Cancer, December 1, 2005; 12(4): 999 - 1009. [Abstract] [Full Text] [PDF]

				D. Xiao, D. Chinnappan, R. Pestell, C. Albanese, and H. C. Weber Bombesin Regulates Cyclin D1 Expression through the Early Growth Response Protein Egr-1 in Prostate Cancer Cells Cancer Res., November 1, 2005; 65(21): 9934 - 9942. [Abstract] [Full Text] [PDF]

				S. Zitzmann, S. Kramer, W. Mier, M. Mahmut, J. Fleig, A. Altmann, M. Eisenhut, and U. Haberkorn Identification of a New Prostate-Specific Cyclic Peptide with the Bacterial FliTrx System J. Nucl. Med., May 1, 2005; 46(5): 782 - 785. [Abstract] [Full Text] [PDF]

				T. Maina, B. A. Nock, H. Zhang, A. Nikolopoulou, B. Waser, J.-C. Reubi, and H. R. Maecke Species Differences of Bombesin Analog Interactions with GRP-R Define the Choice of Animal Models in the Development of GRP-R-Targeting Drugs J. Nucl. Med., May 1, 2005; 46(5): 823 - 830. [Abstract] [Full Text] [PDF]

				J. Schuhmacher, H. Zhang, J. Doll, H. R. Macke, R. Matys, H. Hauser, M. Henze, U. Haberkorn, and M. Eisenhut GRP Receptor-Targeted PET of a Rat Pancreas Carcinoma Xenograft in Nude Mice with a 68Ga-Labeled Bombesin(6-14) Analog J. Nucl. Med., April 1, 2005; 46(4): 691 - 699. [Abstract] [Full Text] [PDF]

				J. B. Engel, G. Keller, A. V. Schally, G. Halmos, B. Hammann, and A. Nagy Effective Inhibition of Experimental Human Ovarian Cancers with a Targeted Cytotoxic Bombesin Analogue AN-215 Clin. Cancer Res., March 15, 2005; 11(6): 2408 - 2415. [Abstract] [Full Text] [PDF]

				A. Stangelberger, A. V. Schally, J. L. Varga, M. Zarandi, K. Szepeshazi, P. Armatis, and G. Halmos Inhibitory Effect of Antagonists of Bombesin and Growth Hormone-Releasing Hormone on Orthotopic and Intraosseous Growth and Invasiveness of PC-3 Human Prostate Cancer in Nude Mice Clin. Cancer Res., January 1, 2005; 11(1): 49 - 57. [Abstract] [Full Text] [PDF]

				J. C. Reubi, H. R. Macke, and E. P. Krenning Candidates for Peptide Receptor Radiotherapy Today and in the Future J. Nucl. Med., January 1, 2005; 46(1_suppl): 67S - 75S. [Abstract] [Full Text] [PDF]

				H. R. Maecke, M. Hofmann, and U. Haberkorn 68Ga-Labeled Peptides in Tumor Imaging J. Nucl. Med., January 1, 2005; 46(1_suppl): 172S - 178S. [Abstract] [Full Text] [PDF]

				A. Capello, E. P. Krenning, B. F. Bernard, W. A.P. Breeman, M. P. van Hagen, and M. de Jong Increased Cell Death After Therapy with an Arg-Gly-Asp-Linked Somatostatin Analog J. Nucl. Med., October 1, 2004; 45(10): 1716 - 1720. [Abstract] [Full Text] [PDF]

				H. Zhang, J. Chen, C. Waldherr, K. Hinni, B. Waser, J. C. Reubi, and H. R. Maecke Synthesis and Evaluation of Bombesin Derivatives on the Basis of Pan-Bombesin Peptides Labeled with Indium-111, Lutetium-177, and Yttrium-90 for Targeting Bombesin Receptor-Expressing Tumors Cancer Res., September 15, 2004; 64(18): 6707 - 6715. [Abstract] [Full Text] [PDF]

				U. Scheffel and M. G. Pomper PET Imaging of GRP Receptor Expression in Prostate Cancer J. Nucl. Med., August 1, 2004; 45(8): 1277 - 1278. [Full Text] [PDF]

				X. Chen, R. Park, Y. Hou, M. Tohme, A. H. Shahinian, J. R. Bading, and P. S. Conti microPET and Autoradiographic Imaging of GRP Receptor Expression with 64Cu-DOTA-[Lys3]Bombesin in Human Prostate Adenocarcinoma Xenografts J. Nucl. Med., August 1, 2004; 45(8): 1390 - 1397. [Abstract] [Full Text] [PDF]

				A. Latil, I. Bieche, L. Chene, I. Laurendeau, P. Berthon, O. Cussenot, and M. Vidaud Gene Expression Profiling in Clinically Localized Prostate Cancer: A Four-Gene Expression Model Predicts Clinical Behavior Clin. Cancer Res., November 15, 2003; 9(15): 5477 - 5485. [Abstract] [Full Text] [PDF]

				J. C. Reubi Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy Endocr. Rev., August 1, 2003; 24(4): 389 - 427. [Abstract] [Full Text] [PDF]

				J. C. Reubi, B. Waser, W. Vale, and J. Rivier Expression of CRF1 and CRF2 Receptors in Human Cancers J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3312 - 3320. [Abstract] [Full Text] [PDF]

				L. Levine, J. A. Lucci III, B. Pazdrak, J.-Z. Cheng, Y.-S. Guo, C. M. Townsend Jr., and M. R. Hellmich Bombesin Stimulates Nuclear Factor {kappa}B Activation and Expression of Proangiogenic Factors in Prostate Cancer Cells Cancer Res., July 1, 2003; 63(13): 3495 - 3502. [Abstract] [Full Text] [PDF]

				W. A.P. Breeman, M. de Jong, J. L. Erion, J. E. Bugaj, A. Srinivasan, B. F. Bernard, D. J. Kwekkeboom, T. J. Visser, and E. P. Krenning Preclinical Comparison of 111In-Labeled DTPA- or DOTA-Bombesin Analogs for Receptor-Targeted Scintigraphy and Radionuclide Therapy J. Nucl. Med., December 1, 2002; 43(12): 1650 - 1656. [Abstract] [Full Text] [PDF]

				Y. Xie, T. C. Gibbs, Y. V. Mukhin, and K. E. Meier Role for 18:1 Lysophosphatidic Acid as an Autocrine Mediator in Prostate Cancer Cells J. Biol. Chem., August 30, 2002; 277(36): 32516 - 32526. [Abstract] [Full Text] [PDF]

				J.-C. Saurin, M. Fallavier, B. Sordat, J.-C. Gevrey, J.-A. Chayvialle, and J. Abello Bombesin Stimulates Invasion and Migration of Isreco1 Colon Carcinoma Cells in a Rho-dependent Manner Cancer Res., August 15, 2002; 62(16): 4829 - 4835. [Abstract] [Full Text] [PDF]

				J. C. Reubi, S. Wenger, J. Schmuckli-Maurer, J.-C. Schaer, and M. Gugger Bombesin Receptor Subtypes in Human Cancers: Detection with the Universal Radioligand 125I-[D-TYR6, {beta}-ALA11, PHE13, NLE14] Bombesin(6-14) Clin. Cancer Res., April 1, 2002; 8(4): 1139 - 1146. [Abstract] [Full Text] [PDF]

				L.-F. Lee, J. Guan, Y. Qiu, and H.-J. Kung Neuropeptide-Induced Androgen Independence in Prostate Cancer Cells: Roles of Nonreceptor Tyrosine Kinases Etk/Bmx, Src, and Focal Adhesion Kinase Mol. Cell. Biol., December 15, 2001; 21(24): 8385 - 8397. [Abstract] [Full Text] [PDF]

				C. Van de Wiele, F. Dumont, R. A. Dierckx, S. H. Peers, J. R. Thornback, G. Slegers, and H. Thierens Biodistribution and Dosimetry of 99mTc-RP527, a Gastrin-Releasing Peptide (GRP) Agonist for the Visualization of GRP Receptor-Expressing Malignancies J. Nucl. Med., November 1, 2001; 42(11): 1722 - 1727. [Abstract] [Full Text] [PDF]

				J. C. Reubi, M. Gugger, B. Waser, and J.-C. Schaer Y1-Mediated Effect of Neuropeptide Y in Cancer: Breast Carcinomas as Targets Cancer Res., June 1, 2001; 61(11): 4636 - 4641. [Abstract] [Full Text] [PDF]

				M. Sumitomo, M. I. Milowsky, R. Shen, D. Navarro, J. Dai, T. Asano, M. Hayakawa, and D. M. Nanus Neutral Endopeptidase Inhibits Neuropeptide-mediated Transactivation of the Insulin-like Growth Factor Receptor-Akt Cell Survival Pathway Cancer Res., April 1, 2001; 61(8): 3294 - 3298. [Abstract] [Full Text]

				M. Sumitomo, R. Shen, J. S. Goldberg, J. Dai, D. Navarro, and D. M. Nanus Neutral Endopeptidase Promotes Phorbol Ester-induced Apoptosis in Prostate Cancer Cells by Inhibiting Neuropeptide-induced Protein Kinase C {{delta}} Degradation Cancer Res., December 1, 2000; 60(23): 6590 - 6596. [Abstract] [Full Text]

				R. E. Carroll, K. A. Matkowskyj, M. S. Tretiakova, J. F. Battey, and R. V. Benya Gastrin-releasing Peptide Is a Mitogen and a Morphogen in Murine Colon Cancer Cell Growth Differ., July 1, 2000; 11(7): 385 - 393. [Abstract] [Full Text]

				M. Gugger and J. C. Reubi Gastrin-Releasing Peptide Receptors in Non-Neoplastic and Neoplastic Human Breast Am. J. Pathol., December 1, 1999; 155(6): 2067 - 2076. [Abstract] [Full Text] [PDF]